Piscataqua Savings Bank Cardiol Therapeutics Inc. Transaction History
Piscataqua Savings Bank
- $109 Million
- Q1 2025
A detailed history of Piscataqua Savings Bank transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Piscataqua Savings Bank holds 5,000 shares of CRDL stock, worth $5,450. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,000
Previous 5,000
-0.0%
Holding current value
$5,450
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CRDL
# of Institutions
42Shares Held
7.61MCall Options Held
4.9KPut Options Held
3.8K-
Tejara Capital LTD London, X03.12MShares$3.4 Million2.61% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD882KShares$961,9110.23% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9796KShares$867,2310.31% of portfolio
-
Pvg Asset Management Corp Golden, CO487KShares$531,1513.54% of portfolio
-
Lion Street Advisors, LLC334KShares$363,7600.11% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $67.5M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...